Pfizer Inc. (PFE)
Pfizer is a global pharmaceutical giant that researches, develops, and manufactures medicines and vaccines to treat a wide range of human health conditions.
Is Pfizer Inc. a good stock for a UK beginner?
The honest version: Pfizer is a global pharmaceutical giant that researches, develops, and manufactures medicines and vaccines to treat a wide range of human health conditions.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Breakthroughs in high-growth areas like oncology
Failure to innovate and loss of patent protection on major drugs
What does Pfizer Inc. do?
Pfizer makes its money by discovering new drugs and selling them to healthcare providers and pharmacies worldwide. After a massive surge in demand for its pandemic-related products, the company is now focused on growing its core business through new drug launches and acquisitions. How successfully they can replace the revenue from their older, best-selling products with new treatments currently in their pipeline will decide a lot.
On our factor screen it looks strongest on value and income, and weakest on growth.
- ✓Pays a dividend - about 6.9% a year
- ✓Growing - revenue up about 5% over the year
- Extensive global distribution network
- Strong history of paying dividends to shareholders
- High gross margins indicating efficient production
- Growth screens low (25/100)
- Patent expirations leading to loss of exclusivity
- Strict government regulation on drug pricing
- High costs and uncertainty associated with clinical trials
What do Pfizer Inc.'s numbers mean?
How much money does Pfizer Inc. make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does Pfizer Inc. pay a dividend?
Yes - Pfizer Inc. currently pays a dividend of about 6.9% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
When does Pfizer Inc. report earnings, and how did recent quarters go?
Pfizer Inc. is next scheduled to report on about 2026-08-04 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-05-05 | $0.72 | $0.75 | Beat +4% |
| 2026-02-03 | $0.57 | $0.66 | Beat +16% |
| 2025-11-04 | $0.63 | $0.87 | Beat +37% |
| 2025-08-05 | $0.57 | $0.78 | Beat +36% |
| 2025-04-29 | $0.67 | $0.92 | Beat +36% |
| 2025-02-04 | $0.46 | $0.63 | Beat +37% |
Across the last 6 quarters here, Pfizer Inc. came in ahead of what analysts expected 6 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for Pfizer Inc.?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of Pfizer Inc.?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Extensive global distribution network
- Strong history of paying dividends to shareholders
- High gross margins indicating efficient production
- Lower volatility compared to the broader market
- Recent decline in annual earnings
- Heavy reliance on the success of new drug development
- Significant competition from other pharmaceutical firms
- Patent expirations leading to loss of exclusivity
- Strict government regulation on drug pricing
- High costs and uncertainty associated with clinical trials
The write-up's own warning lights — if these start happening, the case above changes.
- A permanent change in the company's dividend policy
- A major shift in global healthcare legislation
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.